# ‚öîÔ∏è CLINICAL TRIAL DOSSIER

**NCT ID**: NCT00383279  
**Trial Title**: Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer  
**Patient ID**: ayesha_001  
**Generated**: 2025-11-14T19:58:03.528097  
**Generated By**: JR2 (Dossier Sidekick)

---

## 1. TRIAL OVERVIEW

**Title**: Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer  
**Phase**:   
**Status**: COMPLETED  
**Sponsor**:   
**Estimated Enrollment**: 0  
**Primary Endpoint**: None

**ClinicalTrials.gov**: https://clinicaltrials.gov/study/NCT00383279

---

## 2. ELIGIBILITY ASSESSMENT

**Summary**: 4/5 criteria met

### Eligibility Criteria Table

| Criterion | Status | Confidence | Notes |
|-----------|--------|------------|-------|
| Disease Match | ‚úÖ PASS | 0.90 | Ovarian/gynecologic match: ["cervical cancer", "ovarian cancer", "sarcoma"] |
| Treatment Line | ‚úÖ PASS | 0.80 | Line match assumed (not explicitly excluded) |
| Biomarker Requirements | ‚úÖ PASS | 1.00 | No biomarker requirements |
| Location (NYC Metro) | ‚úÖ PASS | 0.50 | No location data (assume match) |
| Inclusion Criteria (Full Text Available) | üìã REVIEW | 0.80 | See full text: DISEASE CHARACTERISTICS:

* Diagnosis of 1 of the following invasive cancers:

  * Cervical cancer
  * Uterine cancer
  * Ovarian cancer
* Diagnosed ‚â• 6 months ago
* Any stage disease
* Employed at th... |

---

## 3. STRATEGIC SCENARIOS

### Best Case

**Eligibility Probability**: 80.0%

**Scenario**: All pending biomarker tests return favorable results

**Eligibility Level**: HIGH

### Most Likely

**Eligibility Probability**: 80.0%

**Scenario**: 50% of pending tests pass, some may require additional screening

**Eligibility Level**: MODERATE

### Challenge

**Eligibility Probability**: 80.0%

**Scenario**: Some pending tests fail, may need alternative trials

**Eligibility Level**: LOW

---

## 4. TACTICAL RECOMMENDATIONS

| Action | Lab | Cost | Timeline | Priority | Rationale |
|--------|-----|------|----------|----------|----------|
| Proceed with trial enrollment | N/A | N/A | Immediate | HIGH | All eligibility criteria met |

---

## 5. DRUG MECHANISMS

### counseling

**Mechanism (Technical)**: [NEEDS VERIFICATION] Mechanism not found in database for counseling

**Mechanism (Layman)**: [NEEDS VERIFICATION] Please consult oncologist for mechanism explanation.

**Evidence Tier**: UNKNOWN

### study

**Mechanism (Technical)**: [NEEDS VERIFICATION] Mechanism not found in database for study

**Mechanism (Layman)**: [NEEDS VERIFICATION] Please consult oncologist for mechanism explanation.

**Evidence Tier**: UNKNOWN

---

## 6. LOCATION DETAILS

No location data available.

---

## 7. TIMELINE

**Study Start Date**: 

**Primary Completion Date**: 

---

## 8. FULL ELIGIBILITY TEXT

### Inclusion Criteria

DISEASE CHARACTERISTICS:

* Diagnosis of 1 of the following invasive cancers:

  * Cervical cancer
  * Uterine cancer
  * Ovarian cancer
* Diagnosed ‚â• 6 months ago
* Any stage disease
* Employed at the time of diagnosis, defined as working for pay ‚â• 20 hours/week

PATIENT CHARACTERISTICS:

* Not specified

PRIOR CONCURRENT THERAPY:

* Not specified

### Exclusion Criteria

N/A

---

## 9. CONTACT INFORMATION

Contact information not available.

---

## 10. PROVENANCE

**Generated By**: JR2

**Data Sources**: SQLite, Diffbot, DRUG_MECHANISM_DB

**Confidence Flags**: [INFERRED], [NEEDS VERIFICATION]

---

**RESEARCH USE ONLY (RUO)** - This dossier is for research purposes only and should not be used for clinical decision-making without proper medical review.

